Woburn, MA – March 23, 2020 –Kaspersky is happy to today announce free availability of its core endpoint security products for medical organizations in order to help them stay protected from cyberthreats during the COVID-19 pandemic. The full list of B2B products available for free for six months include: Kaspersky Endpoint Security Cloud Plus, Kaspersky Security for Microsoft Office 365, Kaspersky Endpoint Security for Business Advanced and Kaspersky Hybrid Cloud Security.
Continuity of operations and data protection is extremely critical for healthcare organizations. Especially in the uncertainty of today’s healthcare crisis, medical organizations are under extreme pressure and have to mobilize all of their forces to help people during this challenging time. For hospitals and medical institutions, it is important to ensure the stability of medical equipment and that data is constantly available for medical personnel while also protecting the privacy of their patients’ critical information.
To help medical organizations cope with this unprecedented pressure and relieve cybersecurity risks that may arise, Kaspersky is now offering its B2B product solutions available for free. This includes endpoint and cloud infrastructure protection products, such as Kaspersky Endpoint Security for Business Advanced and Kaspersky Hybrid Cloud Security, SaaS endpoint protection like Kaspersky Endpoint Security Cloud Plus, and protection for Microsoft Office 365 via Kaspersky Security for Microsoft Office 365.
“In this critical situation, healthcare institutions are under immense pressure and carry vast responsibility while saving lives and fighting against the COVID-19 virus,” said Evgeniya Naumova, vice president of the global sales network at Kaspersky. “Doctors, nurses and all medical staff take on most of the load and therefore need any support possible, and we feel that it is our duty to support the medical community. In order to help these organizations focus on what matters most, we will now offer healthcare institutions free licenses for key Kaspersky corporate products for a six month period.”
In addition to this initiative, Kaspersky also suggests that medical institutions follow cybersecurity practices and implement the following measures as soon as possible:
For more detailed information about the offering and its availability please visit Kaspersky business blog or contact Kaspersky or its resellers directly.
Kaspersky is a global cybersecurity company founded in 1997. Kaspersky’s deep threat intelligence and security expertise is constantly transforming into innovative security solutions and services to protect businesses, critical infrastructure, governments and consumers around the globe. The company’s comprehensive security portfolio includes leading endpoint protection and a number of specialized security solutions and services to fight sophisticated and evolving digital threats. Over 400 million users are protected by Kaspersky technologies and we help 270,000 corporate clients protect what matters most to them. Learn more at usa.kaspersky.com.